Milan, Italy

Rosa Pallanza

This inventor holds 1 USPTO granted patent. Top assignee: Gruppo Lepetit. Active years: 1985.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rosa Pallanza: Innovator in Antibiotic Development

Introduction

Rosa Pallanza is a notable inventor based in Milan, Italy. She has made significant contributions to the field of antibiotics, particularly through her innovative work on Teichomycin A.sub.2 factors. Her research has the potential to impact the treatment of various microbial infections.

Latest Patents

Rosa Pallanza holds a patent for "Teichomycin A.sub.2 pure single factors 1, 2, 3, 4 and 5 and method for." This invention refers to individual antibiotic substances selected from the group consisting of Teichomycin A.sub.2 factor 1, Teichomycin A.sub.2 factor 2, Teichomycin A.sub.2 factor 3, Teichomycin A.sub.2 factor 4, and Teichomycin A.sub.2 factor 5 in substantially pure form. The method of producing these factors involves recovery from Teichomycin A.sub.2, a known antibiotic substance, using high-efficiency chromatographic methods. The single pure Teichomycin A.sub.2 factors are biologically distinguishable from Teichomycin A.sub.2 due to their higher degree of antibiotic activity against susceptible microorganisms. Rosa Pallanza has 1 patent to her name.

Career Highlights

Rosa is currently associated with Gruppo Lepetit, where she continues her research and development in the field of antibiotics. Her work is crucial in advancing the understanding and application of antibiotic substances.

Collaborations

Rosa Pallanza collaborates with notable colleagues, including Carolina Coronelli and Angelo Borghi. Their combined expertise contributes to the innovative research being conducted at Gruppo Lepetit.

Conclusion

Rosa Pallanza is a pioneering inventor whose work on Teichomycin A.sub.2 factors represents a significant advancement in antibiotic research. Her contributions are vital for the future of microbial infection treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…